Malaria killed about 597,000 people in 2023, according to figures Gavi cites from the World Health Organization. Roughly 95% of those deaths were in Africa, most of them children under five.
In November 2025 Gavi, the vaccine alliance, and UNICEF announced a deal with the Serum Institute of India to cut the price of the R21/Matrix-M malaria vaccine to $2.99 a dose, down from $3.90. The lower price takes effect about a year after the announcement, so late 2026 or early 2027.
The arithmetic
A full course is four doses, so at the new price the vaccine itself costs about $12 per child. Delivery, cold chain and staff add to that, but the vaccine has been one of the larger line items.
By the time of the announcement, 24 African countries had introduced a malaria vaccine into routine childhood immunization, from Benin to Zambia.
Why a price cut is a donation story
A cheaper vaccine changes what a donated dollar buys in two ways.
First, Gavi is short of money. At its June 2025 pledging summit it raised more than $9 billion for 2026 to 2030 against a target of $11.9 billion. A price cut stretches the money it has, but the Center for Global Development has argued that even a successful replenishment would not cover enough R21 or RTS,S doses for the highest-burden countries over the next decade, let alone the cost of getting every dose into an arm.
Second, the vaccine is a complement to, not a replacement for, the malaria programs private donors already fund. GiveWell’s two malaria top charities work on different parts of the problem:
- Against Malaria Foundation funds insecticide-treated bed nets. GiveWell’s 2022 to 2024 average estimate: about $5,500 per life saved.
- Malaria Consortium funds seasonal malaria chemoprevention, monthly preventive medicine for young children during the rainy season. GiveWell’s estimate: about $4,000 per life saved.
The vaccine’s efficacy in trials was around 75% against clinical malaria over a year with a booster, in areas with seasonal transmission. It does not stop transmission, so nets and preventive drugs still matter. Countries that layer all three get the biggest drop in deaths.
What to do with this
If you already give to malaria programs, the price cut is good news that does not change your plan: nets and chemoprevention remain among the cheapest documented ways to prevent a child’s death, and Gavi’s funding gap means the vaccine will not crowd them out.
If you are choosing where to start, the vaccine rollout is mostly funded by governments and Gavi, not by small donors. Individual gifts do more at the margin in the programs above, where a few thousand dollars is a measurable number of lives rather than a rounding error in a multilateral budget.
Method notes
Price and dose figures are from the Gavi press release of November 24, 2025. The $12 per child figure is four doses at $2.99, our arithmetic. Malaria death counts are WHO estimates for 2023 as cited by Gavi. GiveWell figures are their published 2022 to 2024 averages, rounded to the nearest $500.
Sources
Figures come from the cited sources as of the dates shown. Cost-effectiveness estimates change as programs and evidence change; check the source before giving. We are not financial advisers and receive nothing from any charity named here.